186 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
ACAD ACADIA Pharmaceuticals Inc. $14.06 $1.76B Uptrend
Article Searches
Acadia: Poised To Turn https://seekingalpha.com/article/4226077-acadia-poised-turn?source=feed_sector_healthcare Dec 04, 2018 - Acadia has performed well during recent speculative biotech washout.The company's recently announced secondary stock offering threatened to drop the stock back to match its struggling peers.The recent
ACADIA Pharmaceuticals Inc. 2018 Q3 - Results - Earnings Call Slides https://seekingalpha.com/article/4220158-acadia-pharmaceuticals-inc-2018-q3-results-earnings-call-slides?source=feed_sector_healthcare Nov 08, 2018 - The following slide deck was published by ACADIA Pharmaceuticals Inc. in conjunction with their 2018 Q3 earnings call.
ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4219673-acadia-pharmaceuticals-inc-acad-ceo-steve-davis-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Nov 07, 2018 - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2018 Results Earnings Conference Call November 06, 2018 05:00 PM ET Executives Elena Ridloff - SVP, IR and Interim CFO Steve Davis - President and CEO Mich
Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/335688/acadia-pharmaceuticals-acad-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-335688 Nov 06, 2018 - Acadia (ACAD) delivered earnings and revenue surprises of 13.79% and 0.70%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Biotech Stocks Bloodied But Can Now Drive M&A https://seekingalpha.com/article/4212760-biotech-stocks-bloodied-can-now-drive-m?source=feed_tag_etf_portfolio_strategy Oct 19, 2018 - The biotech stocks plunge along with the broader market, as the smallcap and midcap biotech stocks retreat -17%.The larger cap biotechs and pharma are performing relatively much better.The performance
Acadia's Big Scores https://seekingalpha.com/article/4208643-acadias-big-scores?source=feed_sector_healthcare Sep 27, 2018 - Acadia is pretty much a one-therapy company under development for a variety of critical applications.The one FDA-approved indication for Acadia's key therapy, NUPLAZID (pimavanserin), has been under s
Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars http://www.zacks.com/stock/news/324916/biotech-stock-roundup-alxn-soliris-successful-respite-for-sarepta-amrn-soars?cid=CS-ZC-FT-324916 Sep 26, 2018 - Data read-outs by quite a few companies grabbed headlines in the biotech sector this week.
Own A Bond Instead Of Ford - Cramer's Lightning Round (8/22/18) https://seekingalpha.com/article/4201398-bond-instead-ford-cramers-lightning-round-8-22-18?source=feed_tag_cramers_picks Aug 23, 2018 - Dropbox has a great business model.Amgen is cheap compared to Acadia Pharmaceuticals.XPO Logistics is a buy.
Acadia: Nuplazid Troubles Boost Roluperidone Prospects https://seekingalpha.com/article/4197976-acadia-nuplazid-troubles-boost-roluperidone-prospects?source=feed_sector_healthcare Aug 11, 2018 - Possible future competitor to Minerva, Acadia reported decreasing growth visibility and uptake for their drug, Nuplazid.This is likely attributed to recent and relevant safety concerns raised surround
After-Hours Report: SAIL +11.6%, YELP +10.9%, CVNA +10%, ELF -10.2%, ACAD -9.1% on earnings/guidance http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=NS20180808171158AfterHoursReport Aug 08, 2018 - The S&P 500 finished Wednesday slightly lower, ending its four-session winning streak with an uneven

Pages: 123456...19

Page 1>

Related Companies

Name Exchange Price Mkt Cap
PAHC Phibro Animal Health Corporation NASDAQ $43.3 $1.75B
MRTX Mirati Therapeutics, Inc. NASDAQ $54.75 $1.77B
ENTA Enanta Pharmaceuticals, Inc. NASDAQ $91.79 $1.78B
ZGNX Zogenix, Inc. NASDAQ $48.55 $1.74B
CORT Corcept Therapeutics Incorporated NASDAQ $14.74 $1.71B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for ACADIA Pharmaceuticals
ACAD - Google Finance https://www.google.com/finance?q=ACAD Industry related info and international coverage Summary News
ACAD - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=ACAD Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options